Timolol Maleate Solution
Product Images NDC 59651-313

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Timolol Maleate (NDC 59651-313). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aurobindo Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 (Timolo Fig1)

This is a graph showing the Mean Intraocular Pressure (IOP) and standard deviation in millimeters of mercury (mmHg) for two treatment groups in a US study with 191 participants. The treatment groups received either Timolol Maleate Ophthalmic Solution 0.5% once daily or Timolol Maleate Ophthalmic Solution 0.5% twice daily. The x-axis shows the week of the study, while the y-axis shows the mmHg values.*

FDA Label Image

International Study (Timolo Fig2)

This appears to be a chart or a table with numerical values related to an International Study involving 226 participants and a drug called Timolol Maleate. The drug is administered in two forms: Ophthalmic Gel-Forming Solution (.4) and Ophthalmic Olufon (05%) twice a day. There is data on blood pressure (mm Hg) at Trough (Hr 0) and Peak (Hr 2) for the participants over the course of several weeks. The chart appears to be divided into subgroups labeled R, S, I, NS, IS, FS, N, RN, and Week.*

FDA Label Image

Figure A (Timolo Fig3)

FDA Label Image

Figure B (Timolo Fig4)

FDA Label Image

Figure C (Timolo Fig5)

FDA Label Image

Package Label-principal Display Panel (0.5% Container Label)

This is a description for a medication called OBINDO used for ophthalmic purposes (in the eye) once a day. The package insert should also be consulted. The formulation contains Timolol Maleate in a gel-forming solution and should be stored between 15°C to 25°C. The NDC code is 59651-313-05. The medication is produced by Pyrohindo Pharma USA, Inc. The text suggests that the medication is available in India and is for topical use only.*

FDA Label Image

Package Label-principal Display Panel (0.5% – Container-Carton Label)

This is a prescription medication with the NDC 59651-313-05, which is a solution containing Timolol Maleate at 0.5% concentration ( 6.8 mg/mL). It is topically applied in the eye and is sterile. The solution contains preservatives and inactive ingredients, including mannitol and water, while the preservative is benzododecinum bromide. The recommended dosage as per instructions is 1 drop in the eye once a day. The product needs proper storage to prevent freezing and contamination. It is distributed by Aurobindo Pharma USA and is made in India. There is no additional information available.*

FDA Label Image

Chemical Structure (Timolo Str)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.